ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock Cash Flow
NASDAQ:ARCT - Nasdaq - US03969T1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -68.20M | -80.94M | -29.73M | 9.35M | -203.67M | |||
| Depreciation Amortization | 3.44M | 3.54M | 2.96M | 1.53M | 1.19M | |||
| Change In Working Capital | -59.57M | -20.81M | 7.38M | -12.56M | 31.23M | |||
| Interest Paid | 0.00 | 0.00 | 2.13M | 810.00K | 680.00K | |||
| Taxes Paid | N/A | 1.41M | N/A | N/A | N/A | |||
| Other non cash items | 35.00M | 38.46M | 1.29M | 33.67M | 36.21M | |||
| OPERATING CASH FLOW | -89.33M | -59.75M | -18.10M | 31.99M | -135.04M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -545.00K | -648.00K | -2.90M | -7.73M | -3.41M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -545.00K | -648.00K | -2.90M | -7.73M | -3.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -27.36M | -5.00M | 46.60M | |||
| Stock Issued/Repurchased | 3.42M | 5.42M | 3.28M | 2.14M | 1.42M | |||
| FINANCING CASH FLOW | 18.43M | 5.42M | -24.09M | -2.86M | 48.02M | |||
| CHANGE IN CASH | -71.45M | -54.98M | -45.09M | 21.40M | -90.43M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -89.33M | -59.75M | -18.10M | 31.99M | -135.04M | |||
| Capital Expenditure | -545.00K | -648.00K | -2.90M | -7.73M | -3.41M | |||
| FREE CASH FLOW | -89.87M | -60.40M | -21.00M | 24.26M | -138.45M | |||
All data in USD